Prophylactic Pregabalin Treatment Following Spinal Cord Injury
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorLoewenstein Hospital
About this trial
Patients arriving to rehabilitation up to 3 months following SCI will be given (study group) or not (control group) Lyrica (75X2). They will be followed for central pain development.
Eligibility criteria
Qualifiers
Up to 3 months following traumatic or non-traumatic SCL
Ability to give informed consent and cooperate
Disqualifiers
Pregnancy
Neurological or other medical conditions that may interfere with sensation
Neuropathic-like pain before recruitment (described as painful sensation of electric current, burning, numbness, tingling, pricking, or squeezing)
Being treated with Pregabalin
Trial design
Treatments tested in this trial
- Pregabalin 75mg
Treatment groups
50 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov